BioStock: Enzymatica focuses on strengthening the distributor level

Following a promising start to the year with strong initial sales, Enzymatica experienced a decline in sales during the third quarter, primarily attributed to reduced order intake from their key partner, STADA. The company has engaged in discussions with STADA to explore the best way forward, and initiated talks with new possible partners for several of their primary markets. During the third quarter, Enzymatica also presented positive study results that are expected to play a crucial role in market launches, according to an interview with CEO Claus Egstrand.  

Read the full article at biostock.se:

https://www.biostock.se/en/2023/11/enzymatica-focuses-on-strengthening-the-distributor-level/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se